Navigation Links
Aricept Cleared for Advanced Alzheimer's Treatment

Aricept becomes the first drug to be cleared for treatment of all stages of Alzheimer's, the FDA declared on Oct 13. It had been previously approved// for treating the initial stages of the disease. Eisai shares rose on the announcement upto 6,180 yen on the Tokyo Stock Exchange on Monday morning.

Alzheimer's is a progressive disease with no known cure, which affects brain functions of memory and thinking, leading to the patient's death after much mental deterioration. Doctors are already prescribing Aricept for the advanced stages, so the approval only gives an official status to the drug use.

The other drug being used in the US for treating the advanced stages of the disease is Namenda (Forest Laboratories).

Pfizer and Eisai entered an agreement in 1994 for promoting Aricept, which was discovered and developed by Eisai. This approval is likely to see consolidation of Pfizer's share of the Alzheimer's market. Sales of the drug have been forecast at $1.9 billion through March 2007

'"/>




Page: 1

Related medicine news :

1. Is Aricept, the Alzheimer’s Drug Safe to Use against Vascular Dementia
2. ‘Aricept’ drug gives an Alzheimer’s patient reason to smle
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. The Decks Cleared For HRT - Safe for Menopause Symptoms
5. Doctor Cleared Of Charges of Killing a baby
6. Orissa Villagers Jubilant as Girl Cleared Class X Examination
7. Patent for Seminal RNAi innovation Cleared in Australia
8. Risperdal Cleared By FDA To Treat Autistic Children
9. A Woman Dies Due to Breast Cancer After Being Cleared in the Breast Scan
10. Drug For Iron Overload Cleared
11. Advanced STD programs required
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: